Cargando…

Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas

Introduction Adrenal incidentalomas (AI) are adrenal masses that are discovered during radiological examinations conducted for other reasons. In this study, we focused on the pathological and radiological properties of nonfunctional AI(NFAI) and the association with malignancy risk in our clinical s...

Descripción completa

Detalles Bibliográficos
Autores principales: Vural, Veli, Kılınç, Eyyüp M, Sarıdemir, Demet, Gök, İsmail B, Hüseynov, Amil, Akbarov, Alim, Yaprak, Muhittin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001135/
https://www.ncbi.nlm.nih.gov/pubmed/32051792
http://dx.doi.org/10.7759/cureus.6574
_version_ 1783494177876606976
author Vural, Veli
Kılınç, Eyyüp M
Sarıdemir, Demet
Gök, İsmail B
Hüseynov, Amil
Akbarov, Alim
Yaprak, Muhittin
author_facet Vural, Veli
Kılınç, Eyyüp M
Sarıdemir, Demet
Gök, İsmail B
Hüseynov, Amil
Akbarov, Alim
Yaprak, Muhittin
author_sort Vural, Veli
collection PubMed
description Introduction Adrenal incidentalomas (AI) are adrenal masses that are discovered during radiological examinations conducted for other reasons. In this study, we focused on the pathological and radiological properties of nonfunctional AI(NFAI) and the association with malignancy risk in our clinical series. Methods A total of 186 patients underwent adrenalectomy between 2010 and 2017; of these, 76 (40.8%) patients with non-functional AI were included in the current study. The radiological and pathologic characteristics of these AIs were retrospectively analyzed to determine the malignancy rate. Results There were 22 (28.9%) male and 54 (71.1%) female patients with nonfunctional AI included in this study. The median age was 55 (range: 24-85) years. Of the patients included, 37 (48.6%) had AI on the left and 39 (51.3%) had AI on the right adrenal gland. Sixty-one (80.2%) cases were treated laparoscopically, four (5.3%) required conversion to open surgery due to intraoperative difficulties such as bleeding and adhesions, and 11 (14.4%) were managed with open adrenalectomy. The rate of malignancy in the tumors with diameters of <4 cm, 4-6 cm, and >6 cm was found to be 0%, 2.9%, and 13.6%, respectively. Conclusions Determining the ideal cutoff value for surgical indication in an NFAI is challenging. Besides the malignancy risk, the rate of silent pheochromacytomas must be taken into account in the surgical decision.
format Online
Article
Text
id pubmed-7001135
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-70011352020-02-12 Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas Vural, Veli Kılınç, Eyyüp M Sarıdemir, Demet Gök, İsmail B Hüseynov, Amil Akbarov, Alim Yaprak, Muhittin Cureus Endocrinology/Diabetes/Metabolism Introduction Adrenal incidentalomas (AI) are adrenal masses that are discovered during radiological examinations conducted for other reasons. In this study, we focused on the pathological and radiological properties of nonfunctional AI(NFAI) and the association with malignancy risk in our clinical series. Methods A total of 186 patients underwent adrenalectomy between 2010 and 2017; of these, 76 (40.8%) patients with non-functional AI were included in the current study. The radiological and pathologic characteristics of these AIs were retrospectively analyzed to determine the malignancy rate. Results There were 22 (28.9%) male and 54 (71.1%) female patients with nonfunctional AI included in this study. The median age was 55 (range: 24-85) years. Of the patients included, 37 (48.6%) had AI on the left and 39 (51.3%) had AI on the right adrenal gland. Sixty-one (80.2%) cases were treated laparoscopically, four (5.3%) required conversion to open surgery due to intraoperative difficulties such as bleeding and adhesions, and 11 (14.4%) were managed with open adrenalectomy. The rate of malignancy in the tumors with diameters of <4 cm, 4-6 cm, and >6 cm was found to be 0%, 2.9%, and 13.6%, respectively. Conclusions Determining the ideal cutoff value for surgical indication in an NFAI is challenging. Besides the malignancy risk, the rate of silent pheochromacytomas must be taken into account in the surgical decision. Cureus 2020-01-06 /pmc/articles/PMC7001135/ /pubmed/32051792 http://dx.doi.org/10.7759/cureus.6574 Text en Copyright © 2020, Vural et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Vural, Veli
Kılınç, Eyyüp M
Sarıdemir, Demet
Gök, İsmail B
Hüseynov, Amil
Akbarov, Alim
Yaprak, Muhittin
Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas
title Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas
title_full Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas
title_fullStr Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas
title_full_unstemmed Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas
title_short Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas
title_sort association between tumor size and malignancy risk in hormonally inactive adrenal incidentalomas
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001135/
https://www.ncbi.nlm.nih.gov/pubmed/32051792
http://dx.doi.org/10.7759/cureus.6574
work_keys_str_mv AT vuralveli associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas
AT kılınceyyupm associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas
AT sarıdemirdemet associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas
AT gokismailb associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas
AT huseynovamil associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas
AT akbarovalim associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas
AT yaprakmuhittin associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas